• $2.3M
    Market Cap
  • -35.29%
    1-Year Change
  • Medical Devices
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 41
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.06
$0.07
$0.07
1-Year Range
$0.06
$0.20
$0.07
Latest Close$0.07
Change
-$0.0009 (-1.30%)
Volume49,500
Market Cap$2.3M
Shares Outstanding33.4M
P/E (TTM)-6.83
Diluted EPS (TTM)-$0.01
Enterprise Value$2.6M

Information as of 05/28/2026

Company Profile

$2.3M
Market Cap
-$338,125.00
Net Income
Sector: Healthcare
Industry: Medical Devices
951 Broken Sound Boulevard, Boca Raton, FL, United States, 33487
561 558 2020

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company operates through two segments: Vycor Medical and NovaVision. Its Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation therapies targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a German-based partner. It primarily serves hospitals and medical professionals. The company was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. operates as a subsidiary of Fountainhead Capital Management Ltd.

Key Executives

  • David Marc Cantor
  • Adrian Christopher Liddell
  • Peter C. Zachariou

Current Ownership Distribution

  • Insiders22.1M (66.13%)
  • Other11.3M (33.87%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)